StonvexLoading…
StonvexStonvexStonvexCore line items from MYSZ's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.39M | $9.36M | $6.06M | $3.48M |
Operating Income | $-1.41M | $-5.74M | $-3.00M | $-1.65M |
Net Income | $-1.48M | $-5.85M | $-2.85M | $-1.51M |
EPS (Diluted) | $-0.31 | $-1.87 | $-1.00 | $-0.58 |
Total Assets | $8.49M | $10.20M | $11.65M | $9.86M |
Total Liabilities | $4.53M | $5.05M | $4.36M | $2.45M |
Cash & Equivalents | $654.00K | $2.30M | $4.49M | $4.28M |
Free Cash Flow OCF − CapEx | $-2.12M | $-5.16M | $-2.82M | $-2.32M |
Shares Outstanding | 4.82M | 4.64M | 3.85M | 3.10M |